Alcon price target raised to $92 from $91 at BTIG

BTIG analyst Ryan Zimmerman raised the firm’s price target on Alcon (ALC) to $92 from $91 and keeps a Buy rating on the shares as the firm rolls forward EPS estimates following Q4 results. The firm views the results as solid and reflective of improving innovation within Alcon to drive top-line growth against the backdrop of a more measured market outlook. The key driver of outperformance for the shares is whether ophthalmic markets improve in FY26. Net of this, its product cadence and profitability appear on steady footing, BTIG adds. The firm further notes that coupled with strong free-cash flow generation, Alcon has optionality in M&A and share buybacks.